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ABSTRACT
Type IIS restriction endonucleases cleave DNA
outside their recognition sequences, and are there-
fore particularly useful in the assembly of DNA from
smaller fragments. A limitation of type IIS restriction
endonucleases in assembly of long DNA sequences
is the relative abundance of their target sites.
To facilitate ligation-based assembly of extremely
long pieces of DNA, we have engineered a new
type IIS restriction endonuclease that combines
the specificity of the homing endonuclease I-SceI
with the type IIS cleavage pattern of FokI. We
linked a non-cleaving mutant of I-SceI, which con-
veys to the chimeric enzyme its specificity for an
18-bp DNA sequence, to the catalytic domain of
FokI, which cuts DNA at a defined site outside the
target site. Whereas previously described chimeric
endonucleases do not produce type IIS-like precise
DNA overhangs suitable for ligation, our chimeric
endonuclease cleaves double-stranded DNA exactly
2 and 6nt from the target site to generate homoge-
neous, 5’, four-base overhangs, which can be
ligated with 90% fidelity. We anticipate that these
enzymes will be particularly useful in manipulation
of DNA fragments larger than a thousand bases,
which are very likely to contain target sites for all
natural type IIS restriction endonucleases.
INTRODUCTION
Restriction endonucleases, which cleave speciﬁc DNA
sequences, are ubiquitous in prokaryotes (1), where their
main function is defense against bacteriophage infection
(2). Type II restriction endonucleases (3), which recognize
speciﬁc sequences of 4–8bp and cleave DNA into predict-
able, homogeneous fragments, have become invaluable
tools for DNA analysis and manipulation. A subset of
these enzymes, the type IIS restriction endonucleases,
cleave DNA outside of their target sequence, and thus
can generate overhangs with sequence unrelated to the
target sequence. This property makes type IIS restriction
endonucleases particularly useful in the assembly of
DNA with speciﬁed sequence from smaller fragments,
where fragments with matching type-IIS–generated ends
are annealed and ligated, leaving an assembled DNA
product without a target-site scar at the ligation junction
(Figure 1).
A limitation of type IIS restriction endonucleases
in long DNA assembly is the relative abundance of
their target sites. Type IIS restriction endonucleases rec-
ognize non-palindromic sequences of 5, 6 or 7bp, which
are found at an average frequency of one in 512 (4
5/2),
2048 (4
6/2), or 8192 (4
7/2) base pairs, respectively. While it
is relatively easy to identify a type IIS restriction endonu-
clease that does not cut inside a typical gene-sized DNA
fragment of approximately 1kb (4), signiﬁcantly longer
fragments are likely to contain all known type IIS target
sequences, and thus cannot be easily excised from a vector
in order to be joined to another fragment. This is becom-
ing a major limitation in the postgenomic era, when the
availability of genomic information has led to the interest
in the synthesis and manipulation of long DNA fragments
such as operons, eukaryotic regulatory elements, chromo-
somes, and entire genomes (5–13).
We set out to design a novel type IIS restriction endo-
nuclease with a signiﬁcantly longer target site than that
of naturally occurring enzymes of this class, to be used
in ligation-based assembly of extremely long (kb–Mb)
pieces of DNA. To this end we linked the DNA-cleavage
domain of the type IIS restriction endonuclease FokI to a
non-cleaving mutant of the homing endonuclease I-SceI
(Figure 2).
FokI from Flavobacterium okeanokoites, the most
thoroughly studied type IIS restriction endonuclease,
recognizes a 5-bp stretch of DNA and cuts the two
DNA strands 9 and 13 bases (9/13) downstream from
the target sequence, generating four-base, 50 overhangs
(14). The structure of FokI consists of three units: the
DNA-binding domain, which comprises three helix-turn-
helix subdomains (two of which speciﬁcally bind DNA);
a ﬁfteen-residue linker; and a 196-residue, C-terminal,
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DNA complex (15), the catalytic domain is bound to the
DNA-recognition domain, instead of to DNA, revealing a
putative mechanism in which sequestration of the catalytic
domain may contribute to the speciﬁcity of DNA cleavage
(16). The structure of the FokI dimer in the absence of
DNA indicates that dimerization is mediated by the cata-
lytic domains (17), and computational modeling has been
used to explain how each of the catalytic domains in the
dimer are positioned to cleave one DNA strand (17).
Biochemical evidence indicates that FokI cuts DNA as
a dimer (18), with the DNA-recognition domain of one
monomer associated with the FokI target sequence.
The role of the DNA-recognition domain of the second
FokI monomer is not yet clear, but it may be involved in
stabilizing the dimer (19). Recent work shows that a
second FokI target site can lead to FokI-mediated DNA
looping between the two sites (20–22) and enhance cleav-
age by at least 10-fold (23,24).
The domain-level separation of DNA-recognition and
DNA-cleavage functions of FokI makes it an attractive
starting point for the design of restriction endonucleases
with novel speciﬁcities. The catalytic domain of FokI
has previously been fused to diﬀerent DNA-recognition
domains such as Drosophila Ultrabithorax homeodomain
(25), zinc ﬁnger domains (26–29), Za Z-DNA binding
domain (30), yeast Gal4 protein (31), hepatocyte nuclear
factor-3b protein (32), plant APETALA3 (33) and papil-
lomavirus E2 protein (34). The resulting chimeric enzymes
were found to cleave DNA outside of the sequence recog-
nized by the DNA-recognition domain, but with relatively
low activity and speciﬁcity. In particular, since the chi-
meric enzymes cut DNA at a number of adjacent posi-
tions, they do not generate well-deﬁned overhangs such
as those generated by natural type IIS restriction endonu-
cleases, and thus cannot be used to cut and paste speciﬁc
DNA sequences with high ﬁdelity. Zinc-ﬁnger nucleases
with higher eﬃciency were constructed by combining
two DNA target sites, in a face-to-face orientation, by
using a shorter linker between the binding and cleavage
domains (35–37). Such an arrangement led to a double-
stranded break between the two DNA target sites, and is
now widely used for gene targeting (38–56). However,
because the site of DNA cleavage is internal to the overall
target site, these zinc-ﬁnger nucleases also cannot be used
for ligation-based DNA assembly in place of type IIS
endonucleases.
In order to generate a type IIS restriction endonuclease
with an extremely long target site, we fused the catalytic
domain of FokI to an inactive mutant of the I-SceI
homing endonuclease, an enzyme with one of the longest
known target sites (57). I-SceI is encoded on a group I
mitochondrial intron of Saccharomyces cerevisiae (58).
Like other intron-encoded homing endonucleases of
the LAGLIDADG family, I-SceI catalyzes the double-
stranded DNA break required for the lateral transfer of
the intron that encodes it to a homologous allele that lacks
that intron (59). I-SceI recognizes an 18-bp DNA sequence
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Figure 1. Ligation-based DNA assembly using restriction endonucleases. (a) DNA assembly using conventional type II endonucleases requires a type
II recognition site at the junction between the two starting pieces of DNA. The junction remains in the product, precluding the construction of
arbitrary DNA sequences. (b) DNA assembly using type IIS endonucleases, which allow the generation of overhangs of any arbitrary sequence, and
thus sequence-independent construction.
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Figure 2. Overview of strategy for engineering a type IIS restriction
endonuclease with a long recognition site. In the ﬁrst step, the wild-
type I-SceI homing endonuclease is mutated into a variant (Sce7) that
binds but does not cleave DNA. Second, hybrid enzymes are con-
structed between Sce7 and the catalytic domain of the type IIS endo-
nuclease FokI, using designed polypeptide linkers.
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base, 30 overhangs (60–63). Whereas the 18-bp target site
suggests that I-SceI would recognize approximately one
site in a random sequence of 4
18 (10
11) base pairs, I-SceI
has been shown to tolerate some nucleotide substitutions
in its target site, leading to the estimate of about one target
site in a random sequence of 10
8bp (64,65).
To convert I-SceI, which resembles a type II restriction
endonuclease with an extremely long target site, into the
DNA-binding component of a new type IIS restriction
endonuclease, we ﬁrst mutated two essential active-site
aspartatesinI-SceI(66)togenerateaseriesofnon-catalytic
mutants. The most highly expressed non-catalytic mutant,
which still boundthe I-SceI target sequence, was then fused
to the native catalytic domain of FokI using either the
native FokI linker or a series of designed linkers. We
found that the chimeric enzyme with the native FokI
linker (named CdnDI) and the chimeric enzyme with a
designed, 20-residue linker (named CdnDII) both had
type IIS endonuclease activity, cleaving double-stranded
DNA at a speciﬁc distance from the I-SceI target site.
Here we present the design and biochemical characteriza-
tion of these enzymes, as well as the proof-of-concept for
their utility in ligation-based DNA assembly.
MATERIALS AND METHODS
Modeling and design of chimeric enzymes
Structural models were built using the Schro ¨ dinger soft-
ware suite (Schro ¨ dinger, LLC). The FokI dimer [2FOK
(17)] was structurally aligned to the DNA-bound BamHI
dimer [1BHM (67)] using residues 418–579 of FokI and
residues 1–180 of BamHI, leading to the model of a dimer
of FokI catalytic domains bound to DNA.
The FokI dimer was positioned on the DNA down-
stream of the FokI target site [1FOK (15)] by aligning
the DNA backbone adjacent to the original BamHI cleav-
age site in the dimer complex to the known 9/13 site of
FokI cleavage (1FOK: B913–B920, C922–C929; 1BHM:
C1–C8, D5–D12). The wild-type FokI linker, previously
deﬁned as residues 373–387 (15), was modeled as follows:
The backbone dihedral angles of residues 382–387 were
modiﬁed to a-helical, and the backbone dihedral angles
of residues 376–382 were adjusted to create a new back-
bone turn to place the 382–387 helix in line with helical
residues 388–399 of the catalytic domain. Residues
375–389 were minimized and, separately, the Prime
Reﬁne Loops function was applied to generate a series
of low-energy loop conformations. Alternate FokI
models with the catalytic dimer at diﬀerent positions
downstream of the target site were generated by aligning
the same 1BHM DNA base pairs to shifted base pairs of
1FOK. To model the chimeric enzymes, similar align-
ments were used to position the FokI dimer on DNA
downstream of I-SceI [1R7M (66)].
Construction of active-site mutants of I-SceI and of
chimeric endonucleases
All DNA constructs used in this study were assembled
from synthetic oligonucleotides using the Codon Devices
commercial PCR- and ligation-based DNA-assembly
methods and error-correction technology (68). The eight
I-SceI variant genes constructed in addition to the wild-
type I-SceI gene contained all possible single and double
mutations of Asp 44 and Asp 145 to either alanine or
asparagine (Figure 1S). Genes for the chimeric endonu-
cleases were assembled from an upstream fragment of
DNA encoding the inactive, DNA-binding I-SceI variant
Sce7 (D44N, D145A); a middle fragment of DNA encod-
ing a 10-, 15- or 20-residue linker; and a downstream
fragment of DNA encoding the wild-type catalytic
domain of FokI. The protein sequences of the chimeric
endonucleases described in this report are detailed in the
legend of Table 1. Each I-SceI variant gene and
chimeric-endonuclease gene was cloned between the
NcoI and XhoI sites of vector pBAD-His (A)
(Invitrogen, Carlsbad, CA), transformed into Top10
OneShot cells (Invitrogen), and plated onto LB agar
with 100mg/ml of carbenicillin (LB/carb).
Screen for high expression level of I-SceI mutant
proteins in E. coli
To test the expression level of each I-SceI mutant, individ-
ual colonies were used to inoculate 1ml of LB/carb, and
grown overnight, with shaking, at 378C. Ninety microli-
ters of the overnight culture was added to 3ml of fresh LB,
and grown for 2.5–3h, to mid-log phase, at 378C.
Arabinose was added to each culture to 0.02%, and the
cultures were incubated for three more hours at 378C. The
cell pellets were recovered by centrifugation (10min at
3220g,4 8C), stored frozen at –208C, then thawed on ice
and lysed in 350ml of 50mM sodium phosphate, pH 7.0,
0.5M NaCl, 50mM MgCl2, 0.5mg/ml lysozyme, 0.05mg/
ml DNaseI, and 1  EDTA-free COMPLETE protease
inhibitor cocktail (Roche, Indianapolis, IN). Cellular
debris was removed by centrifugation for 2min at
16000g,4 8C. Thirty microliters of 50% slurry of
TALON Superﬂow Metal Aﬃnity Resin (Clontech,
Mountain View, CA), pre-equilibrated with 50mM
sodium phosphate, pH 7.0, 0.5M NaCl and 50mM
MgCl2, were added to each, and the mixtures were
rocked for an hour at 48C. Each resin was washed three
times with 400ml of ice-cold PBS, pH 7.4, then resus-
pended in 25ml of PBS. The resuspended resin was com-
bined with reducing SDS–PAGE buﬀer, boiled at 998C for
5min, separated on 4–12% Bis/Tris gradient gels in MES-
based buﬀer (Invitrogen), and detected with GelCode Blue
(Pierce, Rockford, IL) (Figure 1S).
Purification of I-SceI variant Sce7 and chimeric
endonucleases
A single colony harboring the sequence-veriﬁed gene
of interest was grown in 100ml LB/carb overnight, with
shaking, at 378C. The overnight culture of Sce7 was
diluted 1/33 into the ﬁnal volume of 2l of fresh LB/carb,
grown in shaker ﬂasks for 2.5–3h, at 378C, to mid-log
phase, induced by adding arabinose to 0.02%, grown for
three more hours at 378C, and harvested by centrifugation
for 30min at 4785 g,4 8C. In contrast, chimeric endo-
nucleases were expressed in 4–6l of LB/carb at 258C,
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thawed at 48C in 1/50 of the original culture volume of
10mM HEPES, pH 8.0, 1M NaCl, 1mM DTT, 25mM
imidazole, 1  EDTA-free COMPLETE protease inhibitor
cocktail and 120mg/ml lysozyme. Lysis buﬀer for puriﬁca-
tion of chimeric endonucleases also contained 1mM
PMSF. The lysate was sonicated, then clariﬁed by centri-
fugation for 20min at 6000g,4 8C, followed by ﬁltration of
the supernatant through a 0.45mm ﬁlter. All further puri-
ﬁcation steps were performed at 48C.
The clariﬁed lysate was loaded onto a 1ml HisTrap
column (GE Healthcare, Piscataway, NJ) pre-equilibrated
with 10mM HEPES, pH 8.0, 1M NaCl, 25mM imidazole
and 1mM DTT on the AKTA Puriﬁer chromatography
system (GE Healthcare), at the ﬂow rate of 1ml/min.
The column was washed with 20 column volumes of the
equilibration buﬀer, then eluted with a linear gradient of
25–100mM imidazole in equilibration buﬀer over 30
column volumes. The fractions containing eluted protein
were pooled, concentrated using Amicon (Houston, TX)
Ultra-15 centrifugal concentrators (10kDa MWCO) to
between approximately 1ml, and ﬁltered through a
0.2mm ﬁlter. The partially puriﬁed protein was loaded
onto a HiLoad Superdex 200 16/60 column (GE
Healthcare) pre-equilibrated with 20mM HEPES, pH
8.0, 0.5M NaCl, 1mM DTT, 0.1mM EDTA, and 5%
glycerol on the AKTA Puriﬁer. The size-exclusion chro-
matography step was performed at 0.5ml/min. Fractions
eluted from the column at the volume corresponding to
the expected molecular weight (approximately 38kDa for
the Sce7 mutant and 52kDa for the chimeric endonu-
cleases) were pooled, concentrated using Amicon Ultra-4
centrifugal concentrators (10kDa MWCO) at 2000g,4 8C
(to 160mg/ml for Sce7 and between 100 and 300mg/ml for
the chimeric endonucleases, and stored at –208Ci n1 0m M
HEPES, pH 8.0, 0.25M NaCl, 0.5mM DTT, 0.05mM
EDTA and 50% glycerol.
DNA cleavage assay
To construct a DNA substrate for I-SceI and the chimeric
endonucleases, two complementary oligonucleotides con-
taining the I-SceI target site (50-AATTCTGGTTCCGAA
GCCTGTCCTGCACGCTAGGGATAACAGGGTAA
TAATATATGAATCCAAACTAGAGCGGGGCTCTT
GACGTTTGGCTCAAAACGTCGTGAGACAGTTTG
GTCAGTTGTAAATATCTAATATTCCAATG-30 and
50-GATCCATTGGAATATTAGATATTTACAACTGA
CCAAACTGTCTCACGACGTTTTGAGCCAAACGT
CAAGAGCCCCGCTCTAGTTTGGATTCATATATT
ATTACCCTGTTATCCCTAGCGT GCAGGACAGGC
TTCGGAACCAG-30; the I-SceI target site is underlined)
were annealed, phosphorylated, and ligated between the
EcoRI and BamHI restriction sites of pUC19 (Invitrogen).
The plasmid, named pSCI, was propagated in and
extracted from E. coli OneShot Top 10 (Invitrogen), line-
arized by cleavage with AlwNI (New England Biolabs,
Ipswich, MA) and puriﬁed using standard isopropanol/
acetate precipitation.
To observe cleavage of the linearized, puriﬁed pSCI
substrate by the chimeric endonucleases, 400ng (11nM)
of the plasmid DNA were incubated for 4h under diﬀer-
ent reaction conditions. For the chimeric endonuclease
CdnDI, the optimal cleavage conditions were 50nM endo-
nuclease in 20mM Tris–HCl, pH 9.0, 25mM NaCl,
10mM MgCl2, 1mM dithiothreitol, 0.1mg/ml bovine
serum albumin, and 2% glycerol, at 378C. For the chi-
meric endonuclease CdnDII, the optimal cleavage condi-
tions were 100nM endonuclease in 20mM Tris–HCl, pH
9.0, 25mM NaCl, 10mM MgCl2, 1mM dithiothreitol,
0.1mg/ml bovine serum albumin, and 2% glycerol, at
428C. After the incubation, the products of the reaction
were separated on a 0.8% agarose E-gel (Invitrogen). The
DNA bands were visualized with ultraviolet light and
quantiﬁed by densitometry using an AlphaImager HP
imager (AlphaInnotech, San Leandor, CA) and ImageJ
software (http://rsb.info.nih.gov/ij/).
To test the ability of chimeric endonucleases to cleave
supercoiled DNA, 400ng of circular pSCI were digested
with CdnDI or CdnDII under the optimized cleavage con-
ditions listed above, and the products were separated on a
0.8% agarose E-gel (Invitrogen).
Determination of dissociation constants
The DNA reagent for determining the dissociation
constants between I-SceI variant Sce7 or chimeric endo-
nucleases and DNA was prepared by annealing two
80-base oligonucleotides, 50-GAATTCTGGTTCCGA
AGCCTGTCCTGCACGCTAGGGATAACAGGGTA
ATAATATATGAATCCAAACTAGAGCGGGGCTC
T-30 and 50-AGAGCCCCGCTCTAGTTTGGATTCATA
TATTATTACCCTGTTATCCCTAGCGTGCAGGAC
AGGCTTCGGAACCAGAATTC-30 (the I-SceI target
site is underlined).
To measure the dissociation constants, the binding
protein of interest, at a range of concentrations between
2 and 400nM, was incubated with 10nM DNA substrate
in 20ml of 20mM Tris–HCl, pH 9.0, 25mM NaCl, 10mM
CaCl2, 1mM DTT, 2% glycerol and 0.1mg/ml BSA,
for 20min at 378C (Sce7 and CdnDI) or 428C (CdnDII).
Two microliters of 10  loading buﬀer were added to each
sample, and 10ml of each mixture were loaded onto
6% polyacrylamide DNA retardation gels (Invitrogen),
and run for 30min at 175V. The gels were stained with
SYBR Gold (Invitrogen) and visualized with ultraviolet
light. DNA-containing bands were quantiﬁed by densito-
metry as described above. Concentrations of bound and
free protein were calculated from the input amount of
DNA and from ratios of band intensities, and the data
were ﬁt using Origin software (Originlab, Northampton,
MA) to the following equation:
½Bound protein ¼
½DNA total ½Free protein 
ðKd þ½ Free protein Þ
Determination of cleavage sites of chimeric
endonucleases
Linearized pSCI was cleaved by CdnDI or CdnDII
chimeric endonucleases under optimal cleavage condi-
tions listed above. The resulting 1900-bp and 900-bp
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then extracted from the gel using a Gel Extraction Kit
(Qiagen, Valencia, CA). The 1900-bp fragment was
sequenced using oligonucleotide primer 50-ATTCGCCAT
TCAGGCTGCGC-30, and the 900-bp fragment was
sequenced using oligonucleotide primer 50-CACTTTATG
CTTCCGGCTCG-30. The end of each fragment was
deduced from the point where sequencing data terminated.
Specificity of chimeric endonucleases
Eighteen double-stranded, 80-bp DNA reagents for eval-
uating endonuclease speciﬁcities were constructed as
described above for determination of dissociation con-
stants, except that each reagent contained a single base-
pair substitution in the I-SceI target site. The following
mutations were used in the diﬀerent positions in the
target site: 1: T!C, 2: A!C, 3: G!T, 4: G!T, 5:
G!T, 6: A!C, 7: T!C, 8: A!C, 9: A!C, 10: C!T,
11: A!C, 12: G!T, 13: G!T, 14: G!T, 15: T!C, 16:
A!C, 17: A!C, 18: T!C. The eﬀect of each substitu-
tion on binding was assessed by following the procedure
described above for determination of dissociation con-
stants at 378C, with the following modiﬁcations: For
each of the 18 mutated DNA reagents and for the original
DNA reagent containing wild-type I-SceI target site, each
protein was evaluated at a single concentration, which
corresponded to approximately three times its Kd for the
wild-type I-SceI target sequence (185nM for I-SceI, 40nM
for Sce7, 50nM for CdnDI). The percentage of each DNA
substrate that bound to each protein was determined by
densitometry. Each measurement was conducted three
to four times. For each single-substitution substrate, the
average percentage bound was normalized to the average
percentage bound to the wild-type I-SceI target sequence.
Assembly of DNA fragments generated by chimeric
endonucleases
To test the integrity of 50 overhangs generated by the chi-
meric endonucleases, we carried out ligation-based DNA
assemblies between DNA fragments with CdnD- or BsaI-
generated overhangs. The DNA fragments to be ligated,
Q-Sce, T-Sce, Q-2.567 and T-2.567, were generated by
hybridizing and phosphorylating complementary oligonu-
cleotides, yielding double-stranded DNA with the follow-
ing sequence:
Q-Sce:
TTCATGAGACGATCTCCTTCCTCTTGATGGCTGT
AATAATAGCTCTAGGGCGATGTTAAGACAACG
GATTCATATATTATTACCCTGTTATCCCTAGCGT
GCAGGACAGGCTTCGGAACCTGAG
T-Sce:
TTCAATATATTATTACCCTGTTATCCCTAGCGTG
CAGGACAGGCTTCGGAACCGGAGACGTTGACA
ACATGAAGTAAACAGCGTAAGATGTACCACAT
GAAATTGCGATGAGGAAATCTATGAG
Q-2.567:
TTCATGAGACGATCTCCTTCCTCTTGATGGCTGT
AATAATAGCTCTAGGGCGATGTTAAGACAACTT
CAGAGGCCATGTGAAGGACGCAACATGTGCAG
GTCTCTGTGCGCTCTTCTGTGTGAG
T-2.567:
TTCAGTGTGAAGAGCGTGCTGAGACCGTGCAT
GACTGCGTCATACCAACAGTAGGAGACGTTGA
CAACATGAAGTAAACAGCGTAAGATGTACCAC
ATGAAATTGCGATGAGGAAATCTATGAG
The fragments were cloned into pUC-based vector pTS
(Supplementary Data, Section 3) which had been linear-
ized with BsmBI and BsaI. Vectors based on pTS that
contained inserts Q-Sce, T-Sce, Q-2.567 and T-2.567
were named pTS-Q-Sce, pTS-T-Sce, pTS-Q-2.567 and
pTS-T-2.567, respectively.
To test ligation, each left-hand insert was generated by
digesting donor vector pTS-Q-Sce or pTS-Q-2.567 with
BsmBI and either CdnDI, CdnDII, or BsaI. Each right-
hand insert was generated by digesting donor vector pTS-
T-Sce or pTS-T-2.567 with BtgZI and either CdnDI,
CdnDII, or BsaI. Each enzyme was used under its opti-
mal reaction conditions. The unpuriﬁed digestion products
were combined with the acceptor vector, pCK
(Supplementary Data, Section 3), which had been linear-
ized with BsmBI and BsaI. The mixture was ligated using
T4 DNA ligase (New England Biolabs) and transformed
into One Shot Top 10 chemically competent cells
(Invitrogen). The transformation mixture was plated
onto LB agar plates with 12.5mg/ml chloramphenicol and
25mg/mlkanamycin. Fidelityofligation junctionswascon-
ﬁrmed by DNA sequencing of the entire pCK insert and
insert-vector junctions for 48 colonies per ligation.
RESULTS
Identification of the I-SceI-based DNA-binding module
After mutating the catalytic aspartate residues 44 and
145 of the homing endonuclease I-SceI (66) to either
asparagine or alanine, we found that all eight single and
double mutants were expressed in E. coli at a higher level
than was wild-type I-SceI, with mutant Sce7 (D44N,
D145A) yielding the highest amount of soluble protein
(Figure 1S). Puriﬁed Sce7 does not cut linear, double-
stranded DNA containing the native I-SceI target site
(Figure 3a), but it does bind to that DNA sequence
(Figure 3b and c).
Modeling and design of chimeric enyzmes
In order to gain insight into the design of chimeric endo-
nucleases comprising the FokI cleavage domain, we ﬁrst
investigated the mechanism of wild-type FokI following
the approach previously described by Wah et al. (17). We
were particularly interested in addressing how dimerized
FokI cleavage domains make a double-stranded break in
DNA precisely 9 and 13 bases downstream of the DNA
target site. To compensate for the lack of direct structural
information for FokI bound to and cleaving DNA, we
merged information from the structure of monomeric
FokI bound to DNA in an inactive, sequestered confor-
mation (15); the structure of dimeric FokI without DNA
(17); and a structure of BamHI, a structural homolog
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We assumed that BamHI is a useful model for the orien-
tation of the FokI cleavage domains relative to substrate
DNA due to the structural similarity between the two
endonucleases and the fact that they both produce four-
base, 50 overhangs.
We found that modeling of FokI was able to distinguish
the native 9/13 cleavage pattern from incorrect cleavage
positions. Only with the dimer of FokI catalytic domains
at the 9/13 position can full-length FokI be modeled to
both avoid steric clashes between the DNA-recognition
and catalytic domains, and to allow the two domains to
stay within reach of the 15-residue linker, while preserving
key intramolecular contacts between the beginning of
the linker and the recognition domain. Because of the
intrinsic twist in double-stranded DNA, repositioning
the catalytic domains by even 1bp resulted in a dramatic
change in the distances between the termini of the recog-
nition and catalytic domains. With the cleavage domains
positioned 10/14, the 15-residue linker would be overly
stretched, but a longer linker could be adequate. This
analysis is consistent with the results of previous studies
in which four or seven residues were inserted in the native
linker, leading to cleavage at position 10/14 in addition
to 9/13 (69).
Several criteria were considered in designing the
linkers to connect the I-SceI variant Sce7 to the FokI cat-
alytic domain. Because our goal was a new type IIS endo-
nuclease that would generate well-deﬁned, ligation-quality
overhangs, it was critical that our chimeric enzyme cleave
at a distinct location on DNA. In other words, the linker
should allow the cleavage domain to reach and cut at only
one position downstream of the target site.
Starting with models of dimerized FokI catalytic
domains bound to DNA at diﬀerent positions down-
stream of the I-SceI/Sce7 target site, we eliminated those
models in which Sce7 and either catalytic FokI domain
clashed sterically. From the remaining models, we focused
on those where the C-terminus of Sce7 was within 35A ˚ of
at least one of the N-termini of the catalytic FokI dimer.
Theory for the end-to-end distance of ﬂexible polypeptides
as a function of the number of residues (70,71) indicated
that our new linkers should be in the range of 10–20
residues. We chose mostly polar and charged residues to
maximize the solubility of the linker. To maintain con-
formational ﬂexibility, we avoided amino acids with a
preference for a-helical or b-strand secondary structure
(72,73), and included many glycines. In addition to the
four novel, designed sequences, which comprised two dif-
ferent lengths and two diﬀerent amino-acid compositions,
we included the native, ﬁfteen-residue linker from wild-
type FokI (Table 1).
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Figure 3. Characterization of Sce7. (a) DNA-cleavage assay using lin-
earized plasmid pSCI (6.8nM) which contains a single site recognized
by I-SceI. Lane 1 (S): linearized plasmid; lanes 2 and 3: I-SceI at
275nM and 1.1mM, respectively. Lanes 4 and 5: Sce7 at 140nM and
280nM, respectively. P: DNA fragments resulting from cleavage of
pSCI at the I-SceI recognition site. (b) Sce7 DNA-binding assay, show-
ing DNA band retardation with increasing concentrations of Sce7
(shown in nM). D: double-stranded, linear DNA fragment of 80bp
with a single I-SceI recognition site. C: complex between the DNA
fragment and Sce7. (c) Sce7 binding-aﬃnity curve ﬁt derived from
the gel in (b) using densitometry.
Table 1. The linkers used in the chimeric I-SceI/FokI enzymes and a summary of experimentally determined enzyme cleavage properties
a
Linker sequence Source # AAs Linker name Enzyme name Cleavage at I-SceI
target site
Non-speciﬁc
cleavage
Overhang
QFVIPNRGVTKQLVK FokI 15 FokL CdnDI Yes None 2/6
GGSGDRDDSDPSDKNDGSGG Design 20 20D CdnDII Yes Minor 2/6
GGGSGGSDGSGNGGSGSGGG Design 20 20S Yes Minor 2/6
GGDSRDSDGG Design 10 10D Yes Moderate ND
GGSGGDGSGG Design 10 10S Yes Extensive 1/5
aThe sequence of each full-length chimeric protein was: [MGHHHHHHENLYFQGSGS] [Residues 3–225 of I-SceI as in pdb 1R7M (66)] [Linker as
deﬁned above] [Residues 388–579 of FokI as in pdbs 1FOK (15) and 2FOK (17)]. ND: not determined.
3066 Nucleic Acids Research, 2009, Vol. 37,No. 9Further details of the modeling and design procedures
used and the results obtained are described in Supplemen-
tary Data, Section 2, Table 1S, and Figures 2S and 3S.
Expression and activity of chimeric enzymes
We found that the activity and speciﬁcity of the chimeric
enzymes on linearized plasmid DNA containing a single
copy of the I-SceI target sequence were aﬀected by both
reaction conditions and linker sequence (Figure 4). Under
optimized reaction conditions (4h incubation with 50nM
CdnDI or 100nM CdnDII in 20mM Tris–HCl, pH 9.0,
25mM NaCl, 10mM MgCl2, 1mM dithiothreitol,
0.1mg/ml bovine serum albumin and 2% glycerol; at
378C for CdnDI or 428C for CdnDII), the chimeric
enzymes CdnDI and CdnDII each cut the linearized sub-
strate at a single site to produce two DNA fragments of
the expected length (Figure 5). In addition to this pair of
major products, a minor trace of additional DNA frag-
ments indicative of non-speciﬁc cleavage was observed for
CdnDII. In contrast, the remaining chimeric enzymes pro-
duced additional DNA fragments under the conditions
tested, indicative of cleavage at one or more alternative
sites (Table 1). The addition of excess Sce7 protein
blocked cleavage at the I-SceI target site, but did not
block cleavage at other sites (Figure 5). Under their opti-
mal cleavage conditions, both CdnDI and CdnDII cleaved
supercoiled plasmid DNA that contained a single copy of
the I-SceI target site with eﬃciency comparable to that on
linearized DNA.
Cleavage sites of chimeric enzymes
For wild-type I-SceI and chimeric enzymes CdnDI and
CdnDII, the two products of DNA cleavage were
extracted, puriﬁed, and sequenced in the direction
toward the I-SceI target site to identify the exact location
of the cleavage site for each enzyme (Figure 6). For other
chimeric enzymes, only the two products of DNA cleavage
of length indistinguishable from those found for I-SceI
were extracted, puriﬁed and sequenced.
Sequencing traces for each enzyme tested dropped oﬀ
sharply at a speciﬁc site, which corresponded to the 50 end
of that DNA cleavage product, indicating that DNA
cleavage occurred predominantly at a single position
(Figure 6). For wild-type I-SceI, the sequences of the
DNA products were consistent with the published cleav-
age site within the recognition sequence (62). For all chi-
meric enzymes, the 50 end sequences of the two DNA
S
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Figure 4. DNA cleavage with the hybrid endonuclease CdnDI near its
optimal conditions, showing the eﬀects of single-parameter perturbations.
S:linearized plasmidcontainingasingleI-SceIsite;Sc:wild-typeI-SceI;P:
expected products from single cleavage near the I-SceI site. All samples
contained 11nM linearized plasmid. Samples with CdnDI were incubated
at its optimal conditions (4h, 50nM CdnDI, 20mM Tris–HCl, pH 9.0,
25mM NaCl, 10mM MgCl2, 1mM dithiothreitol, 0.1mg/ml bovine
serum albumin, 2% glycerol, 378C) except for the single parameter
variation as indicated. (a) Eﬀect of pH. (b) Eﬀect of temperature and %
glycerol. (c) Eﬀect of CdnDI concentration and time.
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Figure 5. DNA cleavage by hybrid endonucleases and protection of
substrate DNA from cleavage by excess Sce7. The addition of
110nM Sce7 to any of the three hybrid endonucleases blocks cleavage
at the I-SceI recognition site, but does not block non-speciﬁc cleavage
by CdnDII or the hybrid endonuclease containing the 10S linker. M:
DNA size standards (in base pairs); S: linearized plasmid containing a
single I-SceI site and several FokI sites, without enzyme (11nM in all
assays); Fo: wild-type FokI (2 units); Sc7: Sce7 protein (110nM);
I-SceI: 185nM; CdnDI: 50nM, its optimal conditions; CdnDII:
100nM, its optimal conditions.
Nucleic Acids Research,2009, Vol.37, No. 9 3067products overlapped, indicating that these enzymes pro-
duce 50 overhangs. Often, an additional ‘A’ signal was
observed after the ﬁnal base in a fragment (e.g.
Figure 6b, both traces); we attribute this phenomenon to
the previously described, non-templated addition of ‘A’
(dATP) by the Taq polymerase used in the sequencing
reactions (74). Whereas the ﬁnal ‘A’ signal in the right-
hand trace of Figure 6b does not match the sequence
of the DNA template, and is clearly a product of non-
templated addition, the ﬁnal ‘A’ signal in the left-hand
trace of Figure 6b is less straightforward to interpret due
to the ‘A’ present at that position in the template DNA.
This ﬁnal ‘A’ in this left-hand trace could be either the
result of a non-templated polymerase addition, or else a
part of the true sequencing trace. If it is the result of a
non-templated polymerase addition, the trace indicates
that the CdnDI enzyme produced a four-base, 2/6 over-
hang; alternatively, if it corresponds to an actual ‘A’ in the
fragment sequence, the trace indicates that the enzyme
produced a ﬁve-base, 2/7 overhang. We distinguished
between these possibilities by testing the left-hand product
of CdnDI for its ability to ligate to four-base overhangs
generated by BsaI, which match the predicted CdnDI 2/6
overhang. The high-ﬁdelity ligation of these test over-
hangs with matching four-base overhangs generated
by BsaI, as described below in the section ‘Assembly
of DNA fragments generated by chimeric enzymes’,
suggested that the ‘A’ signal was indeed due to a non-
templated polymerase addition, and that CdnDI produced
four-base, 2/6 overhangs.
The sequences of DNA fragments produced by CdnDI,
CdnDII and the chimeric enzyme-containing linker 20S all
drop oﬀ at the exact same sites, which correspond to the
ends of four-base, 50 overhangs, two and six bases down-
stream of the target site (2/6). When tested on a substrate
with a diﬀerent DNA sequence downstream of the I-SceI
target site, CdnDI still produced the same four-base, 2/6
overhang. The chimeric enzyme containing linker 10S gen-
erates a four-base, 50, 1/5 overhang (Figure 6c), but the
cleavage pattern of the chimeric enzyme containing linker
10D was not homogenous and reproducible enough for
the cleavage site to be determined (Table 1).
Affinity and specificity of CdnD enzymes for
the I-SceI target site
Binding aﬃnities of puriﬁed I-SceI, Sce7, CdnDI and
CdnDII for the I-SceI target site were estimated using a
gel-retardation assay under conditions that inhibit DNA
cleavage by the active enzymes. We estimated the Kd for
I-SceI to be 62 ( 16)nM, which is similar to its previously
measured Km value of 34nM at pH 9.5 (63). The inactive
homing endonuclease mutant, Sce7, and chimeric enzymes
5’ AGTTTGGATTCATATATTATTACCCTGTTAT            CCCTAGCGTGCAGGACAGGCTTC 3’
3’ TCAAACCTCCGTATATAATAATGGGAC            AATAGGGATCGCACGTCCTGTCCGAAG 5’
5’ TATTATTACCCTGTTATCCCTAGC                   GTGCAGGACAGGCTTCGGAACCA 3’
3’ ATAATAATGGGACAATAGGGATCGCACG                   TCCTGTCCGAAGCCTTGGT 5’
(a) I-SceI
(b) CdnDI
*
*
5’ TATTATTACCCTGTTATCCCTAG                   CGTGCAGGACAGGCTTCGGAACCA 3’
3’ ATAATAATGGGACAATAGGGATCGCAC                   GTCCTGTCCGAAGCCTTGGT 5’
(c) 10S
Figure 6. Run-oﬀ sequencing of puriﬁed cleavage products of I-SceI, CdnDI and the hybrid endonuclease with the 10S linker. Each cleavage product
was sequenced toward the cleavage site. The sharp drop-oﬀ after a particular base indicates the end of the fragment, and thus the site of DNA
cleavage. (a) I-SceI. The fragment ends generated by I-SceI are in agreement with its previously reported internal cleavage site (62). (b) CdnDI. The
overlapping fragments generated by CdnDI indicate 50, four-base overhangs resulting from cuts at positions 2/6 relative to the I-SceI recognition site.
The asterisks denote non-templated additions of ‘A’, as discussed in ‘Results’ section. CdnDII and the hybrid endonuclease with the 20S linker
produced run-oﬀ sequencing results indistinguishable from those for CdnDI. (c) The hybrid enzyme with the 10S linker. The overlapping fragments
generated by this enzyme indicate 50, four-base overhangs resulting from cuts at positions 1/5 relative to the I-SceI recognition site.
3068 Nucleic Acids Research, 2009, Vol. 37,No. 9CdnDI and CdnDII bind substrate DNA more tightly
than does wild-type I-SceI, with the estimated Kd of
12 ( 2), 19 ( 6) and 5.0 ( 1.2), respectively.
The binding speciﬁcities of I-SceI, Sce7 and CdnDI for
the native 18-bp I-SceI target sequence were investigated
by comparing their binding to a series of near-native
target sequences (Figure 7) to their binding to the native
target sequence. For the majority of single-base substitu-
tions, all three proteins retain at least 50% of binding
observed for the native binding sequence, as measured
by the proportion of DNA bound to each protein.
Mutations at positions 10 and 13, however, have signiﬁ-
cant, deleterious eﬀects on binding, with a similar eﬀect on
all three proteins. Overall, the speciﬁcity proﬁle across all
18 positions is essentially unchanged from the wild-type
I-SceI to Sce7 and CdnDI.
Assembly of DNA fragments generated by
chimeric enzymes
We tested the utility of the chimeric endonucleases
CdnDI and CdnDII in ligation-based assembly of DNA
fragments. To assemble a pair of inserts, each was excised
from its donor vector by cutting with a standard type IIS
endonuclease to generate an overhang compatible with the
acceptor vector, and with either CdnDI, CdnDII or BsaI
to generate an overhang for pairing with the second insert.
As described in ‘Materials and Methods’ section, the
donor vectors were designed so that, for each enzyme,
both the fragment containing the recognition sequence
and the fragment separated from the recognition sequence
were tested. The pair of inserts with putative complemen-
tary overhangs were then ligated to each other to test the
junction of interest, ligated into the acceptor vector and
sequenced.
BsaI, a standard type IIS endonuclease that generates
50, four-base overhangs, was used to generate test
overhangs with perfect complementarity to the 50 over-
hang that would be generated by CdnDI or CdnDII if
these enzymes cut in the predicted 2/6 pattern. As shown
in Table 2, ligation of BsaI-generated overhangs to
CdnDI-generated overhangs yielded more than 90% of
clones with the correctly assembled insert. Similar high
ﬁdelity was achieved when CdnDI-generated overhangs
were ligated to complementary CdnDI-generated over-
hangs. Together, these results add further evidence that
CdnDI generates homogeneous, four-base, 50 overhangs,
two and six bases downstream of the target site (2/6).
Ligations that involved one or two CdnDII-generated
fragments had only a slightly lower ﬁdelity (81–96%)
than the ligations of CdnDI-generated fragments, consis-
tent with the same, 2/6 cleavage pattern for the two
endonucleases.
DISCUSSION
This study adds to the large number of designed chimeric
endonucleases engineered by linking the catalytic domain
of FokI (25–37) or the catalytic domain of BmrI (75–77),
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Figure 7. Binding speciﬁcity of I-SceI, Sce7 and CdnDI to near-native I-SceI target sequences. Each of the eighteen positions in the native target
sequence were changed sequentially to a cytosine or thymine. Wild-type I-SceI, the inactive variant Sce7, and the hybrid enzyme CdnDI, each at the
concentration three times of its apparent equilibrium dissociation constant to the native target sequence, were incubated with each variant target
sequence. Protein-bound DNA was separated from free DNA in a gel-retardation assay and quantiﬁed by densitometry.
Table 2. Ligation ﬁdelity for DNA fragments generated by CdnDI
and CdnDII
Enzyme used to generate
each side of junction
Fraction of colonies
with correct sequence
Left side Right side
CdnDI CdnDI 43/48=90%
CdnDI BsaI 45/47=96%
BsaI CdnDI 44/47=91%
CdnDII CdnDII 39/48=81%
CdnDII BsaI 48/50=96%
BsaI CdnDII 42/48=87%
Nucleic Acids Research,2009, Vol.37, No. 9 3069another type IIS endonuclease, to unrelated DNA-binding
domains. What distinguishes our most successful engi-
neered chimeric endonucleases, CdnDI and CdnDII,
from their predecessors is that they each make a single,
double-stranded break in DNA at a precisely deﬁned site
outside their recognition region, in a manner similar to
that of type IIS restriction endonucleases. Previously
described chimeric endonucleases either cleave DNA out-
side their recognition site, but generate a heterogenous
mixture of products (25–28,30–32,34,75–77); or else
cleave at a precisely deﬁned site, which must be located
between two face-to-face recognition sites, as is the case
of some highly eﬃcient zinc-ﬁnger nucleases (35–37,48).
As a consequence, the DNA products of CdnDI and
CdnDII, but not the products of earlier engineered chi-
meric endonucleases, have no sequence restrictions and
can be ligated to complementary sticky ends to generate
deﬁned-sequence products.
Biochemical characterization of ﬁve engineered chi-
meric endonucleases constructed using diﬀerent linkers
revealed that, whereas all ﬁve enzymes cleaved linearized
plasmid containing a single I-SceI target site and produced
the two fragments of the expected size, only CdnDI pro-
duced no trace of additional cleavage products. The other
four chimeric endonucleases produced two or more addi-
tional DNA fragments, indicative of cleavage at a small
number of additional, deﬁned sites. The two highest–
molecular-weight undesired cleavage products, which
were produced at the highest level by the chimeric
enzyme with the 10S linker (Figure 5), are consistent in
size with cleavage of the linearized plasmid at a site that
matches 12 of the 18 bases of the I-SceI target site. One
possible explanation for cleavage at this partially match-
ing site is that Sce7 binds to secondary, lower-aﬃnity sites
and still directs the catalytic domain to cleave DNA due to
decreased catalytic-domain sequestration. In wild-type
FokI, the DNA-recognition domain has been shown to
interact with the catalytic domain, likely sequestering the
catalytic domain from DNA cleavage until the speciﬁc,
high-aﬃnity target site on DNA is found (16). In the chi-
meric enzymes, however, the Sce7 DNA-binding module
would not be expected to sequester the FokI catalytic
domain. Nevertheless, it is possible that, in the case of
the most speciﬁc chimeric enzyme, CdnDI, its relatively
hydrophobic linker promotes nonspeciﬁc interactions
between Sce7 and the catalytic domain, mimicking the
sequestration mechanism of wild-type FokI and thus
protecting this site from cleavage by CdnDI. The more
hydrophilic linkers of the other four chimeric endo-
nucleases tested are less likely to provide such
sequestration-like interactions. An alternative possible
explanation is that the linkers used in the chimeric
enzymes other than CdnDI provide some additional
contacts with DNA that lead to cleavage at the site with
only 12 matching base pairs.
In addition to binding-site speciﬁcity, linkers of diﬀer-
ent length and composition also aﬀect the exact length and
position of overhangs on the cleavage products. Overall,
the results agree with the prediction that a chimeric
enzyme with a shorter, 10-residue linker would cleave
closer to the target site than a chimeric enzyme with a
longer, 20-residue linkers. We ﬁnd that the chimeric
enzyme with the native FokI, ﬁfteen-residue linker cleaves
DNA at the same sites (2/6) as the two chimeric enzymes
with 20-residue linkers, producing 50, four-base overhangs,
while the chimeric enzyme with the ten-residue linker, 10S,
cleaves closer to the target site, at 1/5.
Enzyme characterization under diﬀerent reaction con-
ditions revealed that the parameter with the greatest eﬀect
on activity and speciﬁcity of the chimeric enzymes was
buﬀer pH. For example, CdnDI was completely inactive
at pH 10; active with a signiﬁcant proportion of speciﬁc,
single-site cleavage between pH 8–9.5; and active leading
to complete, non-speciﬁc degradation of substrate DNA
at pH 6–7 (Figure 4a). This eﬀect can be only partially
explained by what is known about the pH dependence
of the two parent endonucleases, FokI and I-SceI. Our
ﬁndings are consistent with the fact that FokI is active
in the pH range of 5–10, with 80% maximum activity or
higher at pH 7–9, and with a sharp drop in activity from
pH 9 to 10 (78). It appears that activity of the FokI
catalytic domain at pH 10 is too low for appreciable cleav-
age by CdnDI on the 2–6h scale, even when the FokI
catalytic domain is positioned on DNA substrate by the
Sce7-binding domain. On the other hand, we cannot easily
explain the loss of cleavage speciﬁcity by CdnDI at pH
6–7. It does not appear likely that the loss of speciﬁcity is
due to Sce7-independent DNA binding and cleavage by
the CdnDI FokI catalytic domain, since it has been shown
that FokI with a binding-deﬁcient recognition domain
does not cleave DNA (18). Also, whereas activity of
wild-type I-SceI activity is optimal at pH 9–10 and
drops sharply as pH decreases to 6, this loss of activity
has been shown to be due primarily to a decrease in
Vmax—not to an increase in Km or a loss of enzyme sta-
bility (63). One remaining possible explanation for the loss
of CdnD speciﬁcity at low pH is that, at low pH, Sce7
gains aﬃnity for other DNA sequences without a change
in aﬃnity for the native target site. The resulting
Sce7-mediated binding to DNA sequences other than the
standard I-SceI target sequence may be the reason for the
observed promiscuous DNA cleavage by the associated
FokI catalytic domain.
We demonstrated that the homogeneous, 50, four-base
overhangs generated by cleavage of our chimeric, type
IIS endonucleases CdnDI and CdnDII can be ligated to
complementary sticky ends with a high ﬁdelity and eﬃ-
ciency. Since the long target sequence of the I-SceI-derived
DNA-recognition domain imparts on our chimeric
endonucleases the speciﬁcity for a much less common
DNA sequence than that recognized by natural type IIS
endonucleases, we expect that CdnDI and CdnDII will be
particularly useful in ligation-based assembly of DNA
fragments in the kilobase to megabase range.
Compared to most natural restriction enzymes, our
engineered, chimeric endonucleases have relatively low
activity. The enzymes must be present in excess of DNA
and incubated for several hours to cleave most of the
substrate. Despite the fact that one of the parent enzymes
for this study, wild-type FokI, cleaves at a similarly slow
rate when only one DNA recognition site is present on the
template (23,24), we cannot rule out the possibility that
3070 Nucleic Acids Research, 2009, Vol. 37,No. 9CdnDI and CdnDII may not turn over, i.e. may not be
true enzymes. Nevertheless, the fact that an easily puriﬁed
amount of CdnDI or CdnDII can be used to cleave micro-
gram amounts of DNA and generate ligation-competent,
homogeneous sticky ends demonstrates that these engi-
neered endonucleases are suﬃciently active for use in
cloning, and will be particularly welcome in situations
that require selectivity beyond that of standard type IIS
enzymes.
Our most successful engineered endonucleases to date,
CdnDI and CdnDII, both recognize the same DNA
sequence and cut at the same distance from the target
site. In the future, the repertoire of type IIS endonucleases
with long target sequences could be expanded by attaching
the FokI catalytic domain to other deactivated homing
endonucleases with diﬀerent target sites or to other
DNA-binding proteins that recognize long DNA
sequences. Alternatively, the Sce7 DNA-recognition
domain described in this study could be engineered to
bind speciﬁcally to diﬀerent sequences, as described pre-
viously for active homing endonucleases (64,79–94).
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